Shaghayegh Haghjooy Javanmard (Shagayegh Haghjooy Javanmard, Shaghayegh Javanmard)

Scopus Author ID ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Topics

Systematic Review

Circulating Tumor

Magnetic Nanoparticles

Breast Cancer Cells

Top Venues

BMC medical education

Advanced pharmaceutical bulletin

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Atefeh Vaezi, Mohadeseh Khoshgoftar, Zahra Teimouri, Shaghayegh Haghjooy Javanmard
A qualitative report on experiences of participants in the young innovative leadership program. BMC medical education 24 (1) (2024)
Safoora Sadat Erfanian, Hourieh Ansari, Shaghayegh Haghjooy Javanmard, Zahra Amini, Ali Hajigholami
The hepatorenal protective effects of silymarin in cancer patients receiving chemotherapy: a randomized, placebo-controlled trial. BMC complementary medicine and therapies 24 (1) (2024)
Atefeh Vaezi, Mohadeseh Khoshgoftar, Zahra Teimouri, Shaghayegh Haghjooy Javanmard
A qualitative report on experiences of participants in the young innovative leadership program. BMC medical education 24 (1) (2024)
Atefeh Vaezi, Mohadeseh Khoshgoftar, Zahra Teimouri, Shaghayegh Haghjooy Javanmard
A qualitative report on experiences of participants in the young innovative leadership program. BMC medical education 24 (1) (2024)
Abolghasem Abbasi Kajani, Laleh Rafiee, Shaghayegh Haghjooy Javanmard, Nasim Dana, Setareh Jandaghian
Carbon dot incorporated mesoporous silica nanoparticles for targeted cancer therapy and fluorescence imaging. RSC advances 13 (14) (2023)
Abolghasem Abbasi Kajani, Laleh Rafiee, Shaghayegh Haghjooy Javanmard, Nasim Dana, Setareh Jandaghian
Carbon dot incorporated mesoporous silica nanoparticles for targeted cancer therapy and fluorescence imaging. RSC advances 13 (14) (2023)
Noushin Mohammadifard, Fahimeh Haghighatdust, Maryam Nasirian, Parisa Zakeri, Kamal Heidari, Shaghayegh Haghjooy Javanmard, Nizal Sarrafzadegan
Sex Differences in the Relation between Comorbidities and Prognosis in Hospitalized Patients with COVID-19. Interdisciplinary perspectives on infectious diseases 2022 (2022)
Nasim Dana, Gordon A Ferns, Reza Nedaeinia, Shaghayegh Haghjooy Javanmard
Leptin signaling in breast cancer and its crosstalk with peroxisome proliferator-activated receptors α and γ. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2022)
Vajihe Azimian Zavareh, Laleh Rafiee, Mohammadali Sheikholeslam, Laleh Shariati, Golnaz Vaseghi, Houman Savoji, Shaghayegh Haghjooy Javanmard
Three-Dimensional <i>in Vitro</i> Models: A Promising Tool To Scale-Up Breast Cancer Research. ACS biomaterials science & engineering 8 (11) (2022)
Abolghasem Abbasi Kajani, Laleh Rafiee, Mohamadmahdi Samandari, Masoud Ayatollahi Mehrgardi, Bahare Zarrin, Shaghayegh Haghjooy Javanmard
Facile, rapid and efficient isolation of circulating tumor cells using aptamer-targeted magnetic nanoparticles integrated with a microfluidic device. RSC advances 12 (51) (2022)
Alieh Gholaminejad, Nasrin Zare, Nasim Dana, Davood Shafie, Arya Mani, Shaghayegh Haghjooy Javanmard
A meta-analysis of microRNA expression profiling studies in heart failure. Heart failure reviews 26 (4) (2021)
Marjan Hajimoradi Javarsiani, Javad Sajedianfard, Shaghayegh Haghjooy Javanmard
The effects of metformin on the hippo pathway in the proliferation of melanoma cancer cells: a preclinical study. Archives of physiology and biochemistry (2020)
Leila Safaeian, Seyed Ebrahim Sajjadi, Hossein Montazeri, Farzaneh Ohadi, Shaghayegh Haghjooy Javanmard
Citral Protects Human Endothelial Cells Against Hydrogen Peroxide-induced Oxidative Stress. Turkish journal of pharmaceutical sciences 17 (5) (2020)
Nasim Dana, Golnaz Vaseghi, Shaghayegh Haghjooy Javanmard
Activation of PPARγ Inhibits TLR4 Signal Transduction Pathway in Melanoma Cancer In Vitro. Advanced pharmaceutical bulletin 10 (3) (2020)
Zarifeh Heidary, Jafar Ghaisari, Shiva Moein, Shaghayegh Haghjooy Javanmard
The double-edged sword role of fibroblasts in the interaction with cancer cells; an agent-based modeling approach. PloS one 15 (5) (2020)
Mansoureh Mirabdollahi, Shaghayegh Haghjooy Javanmard, Hojjat Sadeghi-Aliabadi
In Vitro Assessment of Cytokine Expression Profile of MCF-7 Cells in Response to hWJ-MSCs Secretome. Advanced pharmaceutical bulletin 9 (4) (2019)
Nasim Dana, Golnaz Vaseghi, Shaghayegh Haghjooy Javanmard
Crosstalk between Peroxisome Proliferator-Activated Receptors and Toll-Like Receptors: A Systematic Review. Advanced pharmaceutical bulletin 9 (1) (2019)
Nasrin Zare, Shaghayegh Haghjooy Javanmard, Valiollah Mehrzad, Nahid Eskandari, Amirhosein Kefayat
Evaluation of exosomal miR-155, let-7g and let-7i levels as a potential noninvasive biomarker among refractory/relapsed patients, responsive patients and patients receiving R-CHOP. Leukemia & lymphoma 60 (8) (2019)